-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Identifying Castleman Disease from Non-Clonal Inflammatory Causes of Generalized Lymphadenopathy

Program: Education Program
Session: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
Hematology Disease Topics & Pathways:
Research, Autoimmune disorders, Clinical Research, Education, Diseases, Immune Disorders, Treatment Considerations
Saturday, December 7, 2024, 9:30 AM-10:45 AM

David C. Fajgenbaum, MD

University of Pennsylvania, Philadelphia, PA

Disclosures: Fajgenbaum: EUSA Pharma/Recordati Rare Disease: Consultancy, Research Funding; Sobi, Inc.: Consultancy; Medidata, a Dassault Systemes company: Consultancy.

OffLabel Disclosure:

See more of: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
See more of: Education Program
Previous Presentation | Next Presentation >>